Interestingly, NRP1 mRNA expression is particularly high in the mesenchymal GBM subtype, which is associated with the worst prognosis and elevated TGF-β pathway activity compared with other subtypes (13, 39). This evidence concerns the gene TGFB1 and glioblastoma.